Bioskryb Genomics Launches Resolveseq Longread Early Access
07 Oct 2025 //
BUSINESSWIRE
BioSkryb Secures License for Single-Cell Five-Base Genome Patent
20 Aug 2025 //
BUSINESSWIRE
BioSkryb Genomics and Tecan launch single-cell multiomics workflow
25 Apr 2025 //
BUSINESSWIRE
BioSkryb, Ultima Grant to Boost Oncology Research
23 Apr 2025 //
BUSINESSWIRE
BioSkryb Genomics Launches ResolveSEQ MRD Discovery Solution
08 Jan 2025 //
BUSINESSWIRE
BioXpedia A/S and BioSkryb Genomics Announce European Partnership
21 Sep 2022 //
BUSINESSWIRE
BioSkryb Genomics Launches ResolveOME Early Access Program
31 May 2022 //
BUSINESSWIRE
BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer
30 Jun 2021 //
BUSINESSWIRE

Market Place
Sourcing Support